ISLAND PHARMACEUTICALS LIMITED - Announcements

19.2%

43.5¢

Market Cap $110.3M

Healthcare Biotechnology

Island Pharmaceuticals Ltd is an Australia-based drug repurposing company. The Company is... Island Pharmaceuticals Ltd is an Australia-based drug repurposing company. The Company is focused on areas of unmet need for antiviral therapeutics to address infectious diseases. Its lead asset is ISLA-101, a drug with a safety profile being repurposed for the prevention and treatment of dengue2 fever and other mosquito (or vector) borne diseases. ISLA-101 has been shown to have activity against all four strains of dengue virus as well as other flaviviruses such as Zika virus, West Nile virus, and Yellow Fever virus, as well as Chikungunya virus. While ISLA-101 is an oral formulation, the Company is also considering alternative formulations, including a long-acting oral formulation and intravenous formulations for severe dengue infections. The Company operates a single segment, being research and development activities principally in the geographic regions of Australia and the United States. Its subsidiary is Isla Pharmaceuticals Inc.More

ASX:AFP

Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals (ASX:AFP). With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for stocks in the sector with room to run. Latest:...

Announcements

Filter Results

All Price Sensitive Only

ILA	Application for quotation of securities - ILA		04/12/24	15.51KB	Share
ILA	Application for quotation of securities - ILA		04/12/24	15.74KB	Share
ILA	EGM (Spill Meeting) & Closing Date for Director Nominations		03/12/24	75.97KB	Share
ILA	Scientific Advisory Board Change		02/12/24	147.03KB	Share
ILA	Application for quotation of securities - ILA		27/11/24	15.51KB	Share
ILA	Island Phase 2a readout investor briefing presentation		27/11/24	1.99MB	Share
ILA	Island Phase 2a readout investor briefing		27/11/24	127.27KB	Share
ILA	ISLA-101 shows anti-dengue activity in Phase 2a readout	PRICE SENSITIVE	27/11/24	192.96KB	Share
ILA	Trading Halt	PRICE SENSITIVE	25/11/24	235.47KB	Share
ILA	Receipt of R&D tax refund for FY2024	PRICE SENSITIVE	22/11/24	127.19KB	Share
ILA	Initial Director's Interest Notice - PL		21/11/24	234.27KB	Share
ILA	Final Director's Interest Notice x 2		21/11/24	267.54KB	Share
ILA	Application for quotation of securities - ILA		20/11/24	15.5KB	Share
ILA	Replacement - Results of AGM		19/11/24	180.7KB	Share
ILA	Results of AGM		19/11/24	26.92KB	Share
ILA	Annual General Meeting MD Presentation		19/11/24	2.26MB	Share
ILA	Clinical trial progress update	PRICE SENSITIVE	18/11/24	157.21KB	Share
ILA	Phillip Lynch appointed Executive Chairman		15/11/24	429.26KB	Share
ILA	Application for quotation of securities - ILA		13/11/24	15.5KB	Share
ILA	Investor Presentation		12/11/24	3.09MB	Share
ILA	Board changes		11/11/24	129.24KB	Share
ILA	Investor information session		07/11/24	409.59KB	Share
ILA	Application for quotation of securities - ILA		06/11/24	15.5KB	Share
ILA	Quarterly Activities & Cashflow Report	PRICE SENSITIVE	31/10/24	359.76KB	Share
ILA	Application for quotation of securities - ILA		30/10/24	15.51KB	Share
ILA	Application for quotation of securities - ILA		23/10/24	15.51KB	Share
ILA	Letter to Shareholders, Notice of AGM & Proxy Form		18/10/24	511.17KB	Share
ILA	Application for quotation of securities - ILA		16/10/24	15.51KB	Share
ILA	Becoming a substantial holder		15/10/24	318.48KB	Share
ILA	Change in substantial holding		15/10/24	241.46KB	Share
ILA	Change in substantial holding		15/10/24	272.03KB	Share
ILA	Becoming a substantial holder		15/10/24	651.77KB	Share
ILA	Cleansing Notice		11/10/24	191.25KB	Share
ILA	Application for quotation of securities - ILA		11/10/24	16.08KB	Share
ILA	Application for quotation of securities - ILA		09/10/24	15.5KB	Share
ILA	Investor presentation		08/10/24	2.04MB	Share
ILA	Investor webinar		04/10/24	150.12KB	Share
ILA	Proposed issue of securities - ILA		03/10/24	21.96KB	Share
ILA	Island completes $3.5m Placement	PRICE SENSITIVE	03/10/24	211.23KB	Share
ILA	Phase 2a PROTECT clinical trial dosed & Investor webinar	PRICE SENSITIVE	03/10/24	164.14KB	Share
ILA	Trading Halt	PRICE SENSITIVE	01/10/24	212.16KB	Share
ILA	Final Director's Interest Notice - DB		23/09/24	250.67KB	Share
ILA	Initial Director's Interest Notice - CN		23/09/24	229.16KB	Share
ILA	Investor presentation		19/09/24	1.59MB	Share
ILA	Board changes		19/09/24	157.89KB	Share
ILA	Application for quotation of securities - ILA		18/09/24	15.51KB	Share
ILA	Binding LOI for proposed acquisition of Galidesivir	PRICE SENSITIVE	11/09/24	206.67KB	Share
ILA	Appendix 4G and Corporate Governance Statement		29/08/24	546KB	Share
ILA	Annual Report to shareholders		29/08/24	3.22MB	Share
ILA	Preliminary Final Report	PRICE SENSITIVE	29/08/24	219.38KB	Share
ILA	Phase 2a/b clinical trial update	PRICE SENSITIVE	27/08/24	202.81KB	Share
ILA	ISLA-101 Phase 2a/b clinical trial progresses	PRICE SENSITIVE	07/08/24	896.87KB	Share
ILA	Application for quotation of securities - ILA		07/08/24	15.5KB	Share
ILA	Quarterly Activities & Cashflow Report	PRICE SENSITIVE	31/07/24	366.17KB	Share
ILA	Resignation of Joint Company Secretary		19/07/24	136.75KB	Share
ILA	Investor Presentation - Bioshares		10/07/24	1.86MB	Share
ILA	ISLA-101 Clinical Program Update		03/07/24	157.78KB	Share
ILA	Non-binding term sheet signed with BioCryst	PRICE SENSITIVE	03/07/24	196.42KB	Share
ILA	Trading Halt	PRICE SENSITIVE	01/07/24	561.07KB	Share
ILA	Change of Director Interest Notice - DF		26/06/24	197.57KB	Share
ILA	Application for quotation of securities - ILA		26/06/24	15.5KB	Share
ILA	Change in substantial holding		21/06/24	269.68KB	Share
ILA	Application for quotation of securities - ILA		21/06/24	16.31KB	Share
ILA	Application for quotation of securities - ILA		19/06/24	15.69KB	Share
ILA	Application for quotation of securities - ILA		12/06/24	15.68KB	Share
ILA	Piggy Back Options Closing Date Reminder		06/06/24	190.44KB	Share
ILA	Notification regarding unquoted securities - ILA		06/06/24	18.66KB	Share
ILA	Application for quotation of securities - ILA		05/06/24	15.65KB	Share
ILA	Investor Presentation	PRICE SENSITIVE	03/06/24	3.05MB	Share
ILA	New data leads to proposed ISLA-101 Phase 2 efficiencies	PRICE SENSITIVE	03/06/24	652.16KB	Share
ILA	Application for quotation of securities - ILA		29/05/24	15.65KB	Share
ILA	Grant funding to directly support Phase 2a trial	PRICE SENSITIVE	08/05/24	160.75KB	Share
ILA	Change of Director's Interest Notice x5		06/05/24	300.96KB	Share
ILA	Notification of cessation of securities - ILA		06/05/24	17.29KB	Share
ILA	Quarterly Appendix 4C and Activities Report	PRICE SENSITIVE	30/04/24	344.34KB	Share
ILA	Investor Presentation - Asia Bio Partnering	PRICE SENSITIVE	22/04/24	2.71MB	Share
ILA	Application for quotation of securities - ILA		17/04/24	15.78KB	Share
ILA	Positive data from ISLA-101 Single Ascending Dose study	PRICE SENSITIVE	16/04/24	148.54KB	Share
ILA	Change in substantial holding		04/04/24	109.91KB	Share
ILA	Change in substantial holding		04/04/24	128.46KB	Share
ILA	Change of Director's Interest Notice x 5		04/04/24	288.98KB	Share
ILA	Change in substantial holding		03/04/24	269.95KB	Share
ILA	Top 20 Option Holders & Distribution Schedule		02/04/24	83.38KB	Share
ILA	Security Class Reinstatement to Quotation ILAO	PRICE SENSITIVE	02/04/24	86.14KB	Share
ILA	Updated Trading Policy		27/03/24	245.2KB	Share
ILA	Application for quotation of securities - ILA		27/03/24	16.97KB	Share
ILA	Security Class Suspension from Quotation ILAO	PRICE SENSITIVE	26/03/24	88.32KB	Share
ILA	Application for quotation of securities - ILA		26/03/24	17.19KB	Share
ILA	Update - Proposed issue of securities - ILA		21/03/24	26.18KB	Share
ILA	Results of Rights Issue Offer		19/03/24	81.62KB	Share
ILA	Despatch of Rights Issue documentation		05/03/24	137.83KB	Share
ILA	Letter to ineligible shareholders		05/03/24	138.32KB	Share
ILA	Update - Proposed issue of securities - ILA		26/02/24	26.03KB	Share
ILA	Letter to Optionholders		26/02/24	211.33KB	Share
ILA	Letter to Eligible Shareholders		26/02/24	220.9KB	Share
ILA	Target Market Determination		26/02/24	163.42KB	Share
ILA	Proposed issue of securities - ILA		26/02/24	26.38KB	Share
ILA	Prospectus	PRICE SENSITIVE	26/02/24	668.63KB	Share
ILA	$1.95million Fully Underwritten Rights Issue	PRICE SENSITIVE	26/02/24	142.84KB	Share
ILA	Appendix 4D & Half-Year Financial Statements	PRICE SENSITIVE	26/02/24	662.68KB	Share

ILA Application for quotation of securities - ILA
04/12/24		15.51KB	Share
ILA Application for quotation of securities - ILA
04/12/24		15.74KB	Share
ILA EGM (Spill Meeting) & Closing Date for Director Nominations
03/12/24		75.97KB	Share
ILA Scientific Advisory Board Change
02/12/24		147.03KB	Share
ILA Application for quotation of securities - ILA
27/11/24		15.51KB	Share
ILA Island Phase 2a readout investor briefing presentation
27/11/24		1.99MB	Share
ILA Island Phase 2a readout investor briefing
27/11/24		127.27KB	Share
ILA ISLA-101 shows anti-dengue activity in Phase 2a readout
27/11/24	PRICE SENSITIVE	192.96KB	Share
ILA Trading Halt
25/11/24	PRICE SENSITIVE	235.47KB	Share
ILA Receipt of R&D tax refund for FY2024
22/11/24	PRICE SENSITIVE	127.19KB	Share
ILA Initial Director's Interest Notice - PL
21/11/24		234.27KB	Share
ILA Final Director's Interest Notice x 2
21/11/24		267.54KB	Share
ILA Application for quotation of securities - ILA
20/11/24		15.5KB	Share
ILA Replacement - Results of AGM
19/11/24		180.7KB	Share
ILA Results of AGM
19/11/24		26.92KB	Share
ILA Annual General Meeting MD Presentation
19/11/24		2.26MB	Share
ILA Clinical trial progress update
18/11/24	PRICE SENSITIVE	157.21KB	Share
ILA Phillip Lynch appointed Executive Chairman
15/11/24		429.26KB	Share
ILA Application for quotation of securities - ILA
13/11/24		15.5KB	Share
ILA Investor Presentation
12/11/24		3.09MB	Share
ILA Board changes
11/11/24		129.24KB	Share
ILA Investor information session
07/11/24		409.59KB	Share
ILA Application for quotation of securities - ILA
06/11/24		15.5KB	Share
ILA Quarterly Activities & Cashflow Report
31/10/24	PRICE SENSITIVE	359.76KB	Share
ILA Application for quotation of securities - ILA
30/10/24		15.51KB	Share
ILA Application for quotation of securities - ILA
23/10/24		15.51KB	Share
ILA Letter to Shareholders, Notice of AGM & Proxy Form
18/10/24		511.17KB	Share
ILA Application for quotation of securities - ILA
16/10/24		15.51KB	Share
ILA Becoming a substantial holder
15/10/24		318.48KB	Share
ILA Change in substantial holding
15/10/24		241.46KB	Share
ILA Change in substantial holding
15/10/24		272.03KB	Share
ILA Becoming a substantial holder
15/10/24		651.77KB	Share
ILA Cleansing Notice
11/10/24		191.25KB	Share
ILA Application for quotation of securities - ILA
11/10/24		16.08KB	Share
ILA Application for quotation of securities - ILA
09/10/24		15.5KB	Share
ILA Investor presentation
08/10/24		2.04MB	Share
ILA Investor webinar
04/10/24		150.12KB	Share
ILA Proposed issue of securities - ILA
03/10/24		21.96KB	Share
ILA Island completes $3.5m Placement
03/10/24	PRICE SENSITIVE	211.23KB	Share
ILA Phase 2a PROTECT clinical trial dosed & Investor webinar
03/10/24	PRICE SENSITIVE	164.14KB	Share
ILA Trading Halt
01/10/24	PRICE SENSITIVE	212.16KB	Share
ILA Final Director's Interest Notice - DB
23/09/24		250.67KB	Share
ILA Initial Director's Interest Notice - CN
23/09/24		229.16KB	Share
ILA Investor presentation
19/09/24		1.59MB	Share
ILA Board changes
19/09/24		157.89KB	Share
ILA Application for quotation of securities - ILA
18/09/24		15.51KB	Share
ILA Binding LOI for proposed acquisition of Galidesivir
11/09/24	PRICE SENSITIVE	206.67KB	Share
ILA Appendix 4G and Corporate Governance Statement
29/08/24		546KB	Share
ILA Annual Report to shareholders
29/08/24		3.22MB	Share
ILA Preliminary Final Report
29/08/24	PRICE SENSITIVE	219.38KB	Share
ILA Phase 2a/b clinical trial update
27/08/24	PRICE SENSITIVE	202.81KB	Share
ILA ISLA-101 Phase 2a/b clinical trial progresses
07/08/24	PRICE SENSITIVE	896.87KB	Share
ILA Application for quotation of securities - ILA
07/08/24		15.5KB	Share
ILA Quarterly Activities & Cashflow Report
31/07/24	PRICE SENSITIVE	366.17KB	Share
ILA Resignation of Joint Company Secretary
19/07/24		136.75KB	Share
ILA Investor Presentation - Bioshares
10/07/24		1.86MB	Share
ILA ISLA-101 Clinical Program Update
03/07/24		157.78KB	Share
ILA Non-binding term sheet signed with BioCryst
03/07/24	PRICE SENSITIVE	196.42KB	Share
ILA Trading Halt
01/07/24	PRICE SENSITIVE	561.07KB	Share
ILA Change of Director Interest Notice - DF
26/06/24		197.57KB	Share
ILA Application for quotation of securities - ILA
26/06/24		15.5KB	Share
ILA Change in substantial holding
21/06/24		269.68KB	Share
ILA Application for quotation of securities - ILA
21/06/24		16.31KB	Share
ILA Application for quotation of securities - ILA
19/06/24		15.69KB	Share
ILA Application for quotation of securities - ILA
12/06/24		15.68KB	Share
ILA Piggy Back Options Closing Date Reminder
06/06/24		190.44KB	Share
ILA Notification regarding unquoted securities - ILA
06/06/24		18.66KB	Share
ILA Application for quotation of securities - ILA
05/06/24		15.65KB	Share
ILA Investor Presentation
03/06/24	PRICE SENSITIVE	3.05MB	Share
ILA New data leads to proposed ISLA-101 Phase 2 efficiencies
03/06/24	PRICE SENSITIVE	652.16KB	Share
ILA Application for quotation of securities - ILA
29/05/24		15.65KB	Share
ILA Grant funding to directly support Phase 2a trial
08/05/24	PRICE SENSITIVE	160.75KB	Share
ILA Change of Director's Interest Notice x5
06/05/24		300.96KB	Share
ILA Notification of cessation of securities - ILA
06/05/24		17.29KB	Share
ILA Quarterly Appendix 4C and Activities Report
30/04/24	PRICE SENSITIVE	344.34KB	Share
ILA Investor Presentation - Asia Bio Partnering
22/04/24	PRICE SENSITIVE	2.71MB	Share
ILA Application for quotation of securities - ILA
17/04/24		15.78KB	Share
ILA Positive data from ISLA-101 Single Ascending Dose study
16/04/24	PRICE SENSITIVE	148.54KB	Share
ILA Change in substantial holding
04/04/24		109.91KB	Share
ILA Change in substantial holding
04/04/24		128.46KB	Share
ILA Change of Director's Interest Notice x 5
04/04/24		288.98KB	Share
ILA Change in substantial holding
03/04/24		269.95KB	Share
ILA Top 20 Option Holders & Distribution Schedule
02/04/24		83.38KB	Share
ILA Security Class Reinstatement to Quotation ILAO
02/04/24	PRICE SENSITIVE	86.14KB	Share
ILA Updated Trading Policy
27/03/24		245.2KB	Share
ILA Application for quotation of securities - ILA
27/03/24		16.97KB	Share
ILA Security Class Suspension from Quotation ILAO
26/03/24	PRICE SENSITIVE	88.32KB	Share
ILA Application for quotation of securities - ILA
26/03/24		17.19KB	Share
ILA Update - Proposed issue of securities - ILA
21/03/24		26.18KB	Share
ILA Results of Rights Issue Offer
19/03/24		81.62KB	Share
ILA Despatch of Rights Issue documentation
05/03/24		137.83KB	Share
ILA Letter to ineligible shareholders
05/03/24		138.32KB	Share
ILA Update - Proposed issue of securities - ILA
26/02/24		26.03KB	Share
ILA Letter to Optionholders
26/02/24		211.33KB	Share
ILA Letter to Eligible Shareholders
26/02/24		220.9KB	Share
ILA Target Market Determination
26/02/24		163.42KB	Share
ILA Proposed issue of securities - ILA
26/02/24		26.38KB	Share
ILA Prospectus
26/02/24	PRICE SENSITIVE	668.63KB	Share
ILA $1.95million Fully Underwritten Rights Issue
26/02/24	PRICE SENSITIVE	142.84KB	Share
ILA Appendix 4D & Half-Year Financial Statements
26/02/24	PRICE SENSITIVE	662.68KB	Share

REFRESH

First 2 3 4

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 43.5¢		Change 0.070(19.2%)		Mkt cap ! $110.3M

Open	High	Low	Value	Volume
36.5¢	46.0¢	35.5¢	$1.221M	2.977M

Buyers (Bids)

No.	Vol.	Price($)
2	3939	43.5¢

Sellers (Offers)

Price($)	Vol.	No.
45.0¢	12200	2

View Market Depth

No.	Vol.	Price($)
1	1000	0.435
1	4719	0.430
2	9648	0.420
3	16267	0.400
1	2000	0.395

Price($)	Vol.	No.
0.450	3700	1
0.460	34750	1
0.470	1550	1
0.500	4000	1
0.510	59000	1

Last trade - 16.10pm 19/09/2025 (20 minute delay)

ILA (ASX) Chart

ISLAND PHARMACEUTICALS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories